Okuda K, Yokosuka O, Otake Y, Hayashi H, Yokozeki K, Kashima T, Kobayashi S, Sakuma K, Ohni T, Irie Y
Department of Medicine, Chiba University Hospital, Japan.
J Gastroenterol Hepatol. 1998 Mar;13(3):248-52. doi: 10.1111/j.1440-1746.1998.01551.x.
It has been shown that hepatitis C virus (HCV) infection is closely associated with mixed type cryoglobulinaemia. It is also known that HCV infection is rampant among chronic haemodialysis patients. We studied 531 renal failure patients on maintenance dialysis including 170 with positive HCV antibodies for cryoglobulinaemia, and its incidence was compared with controls which consisted of 242 chronic hepatitis C patients without renal failure and 183 healthy adults. Cryoglobulinaemia was present in 30.6% of dialysis patients with HCV infection, 10.8% of dialysis patients without HCV infection, 29.8% of patients with chronic hepatitis C without renal failure, and 0% of healthy adults. Among the 30 new renal failure patients who were started on dialysis within 6 months, four were positive for HCV antibodies, and one of them had cryoglobulinaemia; of the 26 HCV-negative patients, four (15%) were cryoglobulinaemic. The cryocrit values among dialysis patients were much lower than those of the control cases and other reports on non-dialysis cases. Patients with cryoglobulinaemia were generally younger compared with patients negative for this condition. There was no correlation between cryoglobulinaemia and past blood transfusion, underlying disease or length of dialysis. Cryoglobulinaemic patients seem to develop renal failure at relatively young ages and a considerable proportion of cryoglobulinaemic dialysis patients may have already had cryoglobulinaemia at the time of the start of haemodialysis. There was no indication that the presence of cryoglobulin in serum adversely affects the liver disease nor increases serum virus load in HCV-infected dialysis patients. Thus, it was concluded that although HCV infection has a certain role in the development of cryoglobulinaemia in dialysis patients, they develop cryoglobulinaemia less frequently and produce cryoglobulin to a lesser degree in the presence of HCV infection as compared with non-dialysis patients.
研究表明,丙型肝炎病毒(HCV)感染与混合型冷球蛋白血症密切相关。众所周知,HCV感染在慢性血液透析患者中很猖獗。我们研究了531例维持性透析的肾衰竭患者,其中170例HCV抗体阳性患者患有冷球蛋白血症,并将其发病率与对照组进行比较,对照组包括242例无肾衰竭的慢性丙型肝炎患者和183名健康成年人。HCV感染的透析患者中30.6%存在冷球蛋白血症,无HCV感染的透析患者中10.8%存在冷球蛋白血症,无肾衰竭的慢性丙型肝炎患者中29.8%存在冷球蛋白血症,健康成年人中无冷球蛋白血症。在6个月内开始透析的30例新的肾衰竭患者中,4例HCV抗体阳性,其中1例患有冷球蛋白血症;在26例HCV阴性患者中,4例(15%)患有冷球蛋白血症。透析患者的冷沉淀比容值远低于对照组以及其他非透析病例的报告。与无冷球蛋白血症的患者相比,冷球蛋白血症患者通常更年轻。冷球蛋白血症与既往输血、基础疾病或透析时间无关。冷球蛋白血症患者似乎在相对年轻时就发展为肾衰竭,相当一部分冷球蛋白血症透析患者在开始血液透析时可能已经患有冷球蛋白血症。没有迹象表明血清中冷球蛋白的存在会对肝病产生不利影响,也不会增加HCV感染透析患者的血清病毒载量。因此,得出的结论是,尽管HCV感染在透析患者冷球蛋白血症的发生中起一定作用,但与非透析患者相比,透析患者发生冷球蛋白血症的频率较低,且在HCV感染时产生冷球蛋白的程度较轻。